UnitedHealth Group (NYSE:UNH) Given New $562.00 Price Target at Deutsche Bank Aktiengesellschaft

UnitedHealth Group (NYSE:UNH) had its price target raised by Deutsche Bank Aktiengesellschaft from $545.00 to $562.00 in a research note published on Friday, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the healthcare conglomerate’s stock.

A number of other research analysts have also weighed in on UNH. Oppenheimer reaffirmed an outperform rating and set a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Morgan Stanley reduced their target price on UnitedHealth Group from $618.00 to $584.00 and set an overweight rating for the company in a report on Friday, April 5th. Cantor Fitzgerald reiterated an overweight rating and set a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 10th. HSBC upgraded UnitedHealth Group from a reduce rating to a hold rating and set a $460.00 price target for the company in a research report on Thursday, April 4th. Finally, Barclays lifted their price target on UnitedHealth Group from $534.00 to $560.00 and gave the company an overweight rating in a research report on Wednesday. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of Moderate Buy and a consensus target price of $570.05.

UnitedHealth Group Trading Up 1.6 %

Shares of UNH opened at $501.29 on Friday. The business has a 50-day moving average of $488.63 and a 200 day moving average of $515.13. UnitedHealth Group has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The firm has a market cap of $462.15 billion, a P/E ratio of 30.64, a price-to-earnings-growth ratio of 1.35 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter last year, the firm posted $6.26 EPS. As a group, research analysts forecast that UnitedHealth Group will post 27.74 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.50%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Robbins Farley bought a new position in UnitedHealth Group in the third quarter worth $25,000. Richelieu Gestion SA bought a new position in UnitedHealth Group in the fourth quarter worth $26,000. CGC Financial Services LLC raised its holdings in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares in the last quarter. True Wealth Design LLC bought a new position in UnitedHealth Group in the fourth quarter worth $31,000. Finally, NewSquare Capital LLC raised its holdings in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.